Reata Pharmaceuticals Inc - Class A (RETA) Dividend History
Reata Pharmaceuticals, Inc. is a pharmaceutical company based in Plano, Texas. Founded in 2002, Reata is primarily focused on investigating experimental oral antioxidative and anti-inflammatory drugs, which dually activate the antioxidative transcription factor Nrf2 and inhibit the pro-inflammatory transcription factor NF-κB. The antioxidative and anti-inflammatory compounds bardoxolone methyl and RTA 408 are the lead clinical development compounds in Reata’s portfolio.
Last update 03/18/2023
Dividend Yield Summary
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
| Dividends | - | - | - | - | - | - |
| Average Price | 47.03 | 109.37 | 150.01 | 106.00 | 30.40 | 42.97 |
| Yield | - | - | - | - | - | - |
Dividend History
No history of dividends
| Date | Amount Per Share | Note |